FDA.reportPublic FDA data

Lipofen 150 MG Oral Capsule

RxCUI
702055
RxNorm name
Lipofen 150 MG Oral Capsule
Display name
Lipofen 150 MG Oral Capsule
Full name
Lipofen 150 MG Oral Capsule
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:05

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
LipofenFENOFIBRATEANI Pharmaceuticals, Inc.78b789b9-854f-46b9-97f3-a48759a6ff892026-05-12Warnings, Adverse reactionsExact identifier
rxcui: 702055

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
78b789b9-854f-46b9-97f3-a48759a6ff89Lipofen 150 MG Oral Capsule [PSN] · fenofibrate 150 MG Oral Capsule [Lipofen] [SBD] · Lipofen 150 MG Oral Capsule [SY]33These highlights do not include all the information needed to use LIPOFEN ® safely and effectively. See full prescribing information for LIPOFEN ® . LIPOFEN ® (fenofibrate) capsules, for oral use Initial U.S. Approval: 199320260512